Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$156.8M
-25.6% from 2023
Prescriptions
123K
$1,270.58 per claim
Patients
16K
10,560 prescribers
Total spending, 2024
$156.9M
$9,926.58 per patient
Medicare prescription drug plans paid $156.8M for Imatinib Mesylate in 2024, for 123,429 prescriptions and refills to 15,801 patients (down 25.6% from 2023). The average cost per claim was $1,270.58.
New York had the highest Medicare cost for Imatinib Mesylate in 2024: $19.1M for 10,070 claims, followed by Pennsylvania ($13.9M).
Ping CHI, medical oncology in New York, NY, had the highest Medicare cost for Imatinib Mesylate in 2024: 234 claims costing $609K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Ping CHI New York, NY | Medical Oncology | 234 | 28 | $609K |
| Marisa J Hine New York, NY | Nurse Practitioner | 72 | 11 | $335K |
| Ciara M Kelly |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 9,973 | 119,036 | 14,649 | $263.5M |
| 2023 | 9,949 | 115,874 | 14,601 | $210.9M |
| 2024 | 10,560 | 123,429 | 15,801 | $156.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Oncology |
| 109 |
| 19 |
| $327K |
| Namita Vinayek Springfield, IL | Hematology-Oncology | 44 | Under 11 | $307K |
| Cissimol Joseph Houston, TX | Nurse Practitioner | 152 | 21 | $304K |
| Margaret Von-Mehren Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 183 | 20 | $283K |
| Cynthia Wheeler Philadelphia, PA | Nurse Practitioner | 58 | Under 11 | $276K |
| Ibrahim Sbeitan Johnstown, PA | Medical Oncology | 63 | Under 11 | $250K |
| Anant Sharma Denton, TX | Hematology-Oncology | 42 | Under 11 | $245K |
| Yusuf K Deshmukh Elizabethtown, KY | Hematology-Oncology | 59 | Under 11 | $243K |
| Nancy N Sun Woodbury, NY | Hematology-Oncology | 19 | Under 11 | $242K |
| Tony Philip New Hyde Park, NY | Hematology-Oncology | 117 | 16 | $233K |
| Phillip H Chae Midland, TX | Hematology-Oncology | 51 | Under 11 | $233K |
| Kathleen Polson Boston, MA | Nurse Practitioner | 85 | 22 | $228K |
| Masih U Farooqui Springfield, MA | Hematology-Oncology | 27 | Under 11 | $219K |
| Emily Yam New York, NY | Nurse Practitioner | 15 | Under 11 | $218K |
| Reema A Patel Lexington, KY | Medical Oncology | 183 | 21 | $215K |
| Kevin Brigle Richmond, VA | Nurse Practitioner | 54 | Under 11 | $215K |
| Sandhya Dhanjal Fairfield, CT | Hematology-Oncology | 31 | Under 11 | $214K |
| Michael Voloshin Johnstown, PA | Hematology | 52 | Under 11 | $203K |
| Theresa Nguyen Boston, MA | Nurse Practitioner | 74 | Under 11 | $203K |
| Nathanael D Gay Spokane, WA | Medical Oncology | 30 | Under 11 | $203K |
| Hannah R Schwabe Rochester, NY | Physician Assistant | 83 | 14 | $201K |
| Varant B Arzoumanian Fort Smith, AR | Hematology-Oncology | 63 | Under 11 | $199K |
| Kelli A Cawley Belpre, OH | Hematology-Oncology | 60 | Under 11 | $194K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Aurobindo Pharm AUROPHARMA.NS | 48,237 | $72.1M |
| Sun Pharma Glob SUNPHARMA.NS | 17,853 | $22.1M |
| Teva USA TEVA | 22,309 | $21.6M |
| Apotex Corp | 13,724 | $20.8M |
| Quallent Pharma | 2,481 | $10.4M |
| Bluepoint Labor | 2,689 | $5.0M |
| Dr.Reddy'S Lab RDY | 1,276 | $1.8M |
| Archis Pharma L | 12,804 | $1.2M |
| Upsher-Smith La | 855 | $996K |
| Mylan VTRS | 913 | $763K |
| Mylan Instituti VTRS | 252 | $87K |
| Armas Pharmaceu | 46 | $65K |
| Major Pharmaceu | 24 | $13K |